RTW Charitable Foundation Accelerator
The RTW Charitable Foundation Accelerator, administered by Columbia Technology Ventures, is a strategic research alliance between the RTW Charitable Foundation and select New York-based academic institutions, to accelerate translational research in the field of rare diseases with particular interest in ultra-rare and underfunded rare diseases.
Questions? Please read Program Information below or reach out to the Columbia Alliance Manager Sam Galindo, at [email protected].
Translational projects focused on treatment of rare and ultra-rare diseases in the following areas:
- Central Nervous System
- Immunology/Autoimmunity (non-oncology)
Projects should be aimed towards developing treatments or technologies to improve patient lives.
Applicants must have a full-time faculty appointment at a participating New York-based academic institution.
Participating institutions include:
- Columbia University
- Albert Einstein College of Medicine
- Weill Cornell Medicine
- Mount Sinai School of Medicine
- New York University
Selected research projects will receive up to $125,000 (including a maximum of 10% indirect costs) in philanthropic funding.
Pre-proposals will be reviewed by RTW Charitable Foundation. Selected applicants will be invited to participate in Columbia’s Lab-to-Market Boot Camp (January-May 2022) and to develop a Full Proposal. Full Proposals will be submitted in writing and presented to a committee at the end of the Boot Camp to make final funding decisions.
Pre-Proposal Deadline: 5pm Monday, November 22
Pre-Proposal Decisions Announced: mid-December
Lab-to-Market Boot Camp: January – May 2022
Full Proposals: March 2022
Presentations: April/May 2022
About RTW Charitable Foundation
The RTW Charitable Foundation (RTWCF) works to improve opportunities for all people to live healthier, longer lives and was created at the intersection of scientific advancements and humanitarian efforts. RTWCF is proud to support pioneers who are breaking new ground in the fight against diseases that may not represent compelling commercial opportunities but do result in significant human suffering. The Foundation can provide capital, collaborative leadership, and scientific expertise to help scientists push such projects forward. In addition, the Foundation aims to assist in advocacy, disease awareness and direct support to patients and their families.
For more information, visit rtwcf.org.